Eldad Ben-Chetrit MD
Professor of Medicine, formerly, Head Department of Medicine (1998-2001), and formerly Director of the Rheumatology Unit (2009- 2017) and the FMF Clinic at the Hadassah-Hebrew University Medical Center in Jerusalem.. He is a visiting Professor at the Oklahoma Medical Research Foundation (1996), Stanford University (2004) and McGill Universities (2010). After training in Internal Medicine, Dr Ben-Chetrit was trained in Rheumatology and Immunology at the Scripps Clinic and Research Foundation in La Jolla, California (Lab of Eng Tan MD), In 1990 he gained his Diplome in Rheumatology. His main research interests and publications include: Pathophysiology of Auto-Immune diseases i.e; Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS) and immune related Complete Congenital Heart Block (JCI 1989). He identified the SSA/Ro 52KD protein (JEM 1988) and isolated the gene encoding the SSA/Ro 60KD protein (JCI 1989). His main current interest is in the genetic, pathophysiology and therapeutic response of autoinflammatory diseases mainly, Familial Mediterranean fever (FMF) and Behcet's disease (BD). He also studied extensively the mechanism of action of Colchicine and its pharmacokinetics. He participated in one of the two groups which identified the MEFV gene associated with FMF (Nat Genet 1997). He also participated in the NIH group which found IL-10 SNP association with Behcet's disease (Nat Genet 2012). He also participated in the group which revised the classification criteria for BD. Recently he was in the steering committee of the large trial of canakinumab (anti IL-1 ab) in autoinflammatory diseases (NEJM 2018) and headed the committee for renaming the autoinflammatory diseases and revising their definition. He has published more than 240 original papers, case reports letters and reviews and received many national and international awards.